Kakao Healthcare, the digital healthcare enterprise of South Korean web firm Kakao Company, has partnered with Novo Nordisk to additional develop its diabetes administration service powered by cellular and AI applied sciences.
The 2 organisations lately signed a memorandum of understanding to launch a wise healthcare service to help sufferers with diabetes. In keeping with a press launch, Kakao Healthcare’s digital diabetes administration service, Venture Gamma, will characteristic the French medical machine firm BIOCORP’s Mallya sensible sensor, which Novo Nordisk plans to launch in South Korea a while this 12 months.
Mallya, a wise sensor that attaches to a pre-filled insulin pen, will allow customers to robotically gather and document their each day insulin injection information, together with the variety of insulin items and date and time. The info are transmitted through Bluetooth to the Venture Gamma app the place sufferers can view their dosage logs in real-time, empowering sufferers to handle their very own circumstances anytime, wherever.
Later, Mallya might be synced with the hospital info techniques of the sufferers’ healthcare suppliers.
WHY IT MATTERS
This newest digital diabetes collaboration couldn’t come at a extra opportune time when diabetes circumstances are rising.
In the present day, there are about six million adults, or about one in each six individuals, who stay with diabetes in South Korea, based mostly on the most recent statistics supplied by the Korean Diabetes Affiliation. Their rely is predicted to rise because the inhabitants ages at a faster tempo.
THE LARGER TREND
Kakao Healthcare has been concerned in each native and worldwide initiatives to help sufferers with diabetes by selling digital diabetes administration. Its collaboration with Novo Nordisk adopted its current signing of a global partnership with Dexcom to arrange a diabetes administration service beginning in South Korea later this 12 months.
In the meantime, Novo Nordisk tied up with Health2Sync in Taiwan to allow the latter’s cellular well being app to sync dose logs from the NovoPen sensible insulin pens, in addition to supply a affected person help programme.
ON THE RECORD
“South Korea is likely one of the international locations with essentially the most superior digital atmosphere on the planet, and particularly, its healthcare AI innovation is surprisingly dynamic and thrilling. Sadly, nonetheless, South Korea is ageing on the quickest tempo on the planet, and the variety of Korean sufferers with diabetes can also be growing. We’re very happy to kind a strategic alliance with Kakao Healthcare, a frontrunner within the home digital well being area, and work collectively to offer sensible options that may enhance the well being of six million Koreans affected by diabetes,” Novo Nordisk President Sacha Semienchuk mentioned in an announcement.
“Via our collaboration with Novo Nordisk, sufferers with diabetes, whether or not at house or overseas, will be capable to handle their well being extra simply and conveniently,” Kakao Healthcare CEO Hwang Hee additionally commented.
